Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA. Focused drug supply methods for precision medicines. Nat Rev Mater. 2021;6:351–70.
Arias-Alpizar G, Kong L, Vlieg RC, Rabe A, Papadopoulou P, Meijer MS, et al. Mild-triggered switching of liposome floor cost directs supply of membrane impermeable payloads in vivo. Nat Commun. 2020;11:3638.
Solar T, Zhang Y, Energy C, Alexander PM, Sutton JT, Aryal M, et al. Closed-loop management of focused ultrasound drug supply throughout the blood–mind/tumor obstacles in a rat glioma mannequin. Proc Natl Acad Sci USA. 2017;114:E10281–90.
Erel-Akbaba G, Carvalho LA, Tian T, Zinter M, Akbaba H, Obeid PJ, et al. Radiation-induced focused nanoparticle-based gene supply for mind tumor remedy. ACS Nano. 2019;13:4028–40.
Kooijmans SAA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM. Show of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell concentrating on. J Extracell Vesicles. 2016;5:31053.
Martins-Marques T, Pinho MJ, Zuzarte M, Oliveira C, Pereira P, Sluijter JPG, et al. Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic strategy with doxorubicin. J Extracell Vesicles. 2016;5:32538.
Nojima H, Freeman CM, Schuster RM, Japtok L, Kleuser B, Edwards MJ, et al. Hepatocyte exosomes mediate liver restore and regeneration through sphingosine-1-phosphate. J Hepatol. 2016;64:60–8.
Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, et al. Minimal experimental necessities for definition of extracellular vesicles and their features: a place assertion from the Worldwide Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913.
Cheng Q, Shi X, Han M, Smbatyan G, Lenz H-J, Zhang Y. Reprogramming exosomes as nanoscale controllers of mobile immunity. J Am Chem Soc. 2018;140:16413–7.
Jung KO, Jo H, Yu JH, Gambhir SS, Pratx G. Growth and MPI monitoring of novel hypoxia-targeted theranostic exosomes. Biomaterials. 2018;177:139–48.
Guo X, Lv X, Ru Y, Zhou F, Wang N, Xi H, et al. Circulating exosomal gastric cancer-associated lengthy noncoding RNA1 as a biomarker for early detection and monitoring development of gastric most cancers: a multiphase examine. JAMA Surg. 2020;155:572–9.
Thakur A, Qiu G, Xu C, Han X, Yang T, Ng SP, et al. Label-free sensing of exosomal MCT1 and CD147 for monitoring metabolic reprogramming and malignant development in glioma. Sci Adv. 2020;6:eaaz6119.
Azizi M, Dianat-Moghadam H, Salehi R, Farshbaf M, Iyengar D, Sau S, et al. Interactions between tumor biology and focused nanoplatforms for imaging functions. Adv Func Mater. 2020;30:1910402.
Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges in direction of focused supply of most cancers therapeutics. Nat Commun. 2018;9:1410.
Yang Z, Shi J, Xie J, Wang Y, Solar J, Liu T, et al. Giant-scale era of useful mRNA-encapsulating exosomes through mobile nanoporation. Nat Biomed Eng. 2020;4:69–83.
Rana S, Yue S, Stadel D, Zöller M. Towards tailor-made exosomes: the exosomal tetraspanin net contributes to focus on cell choice. Int J Biochem Cell Biol. 2012;44:1574–84.
Näslund TI, Paquin-Proulx D, Paredes PT, Vallhov H, Sandberg JK, Gabrielsson S. Exosomes from breast milk inhibit HIV-1 an infection of dendritic cells and subsequent viral switch to CD4+ T cells. AIDS. 2014;28:171–80.
Kowal J, Tkach M. Dendritic cell extracellular vesicles. Int Rev Cell Mol Biol. 2019;349:213–49.
Wang Y, Cao Z, Wei Q, Ma Okay, Hu W, Huang Q, et al. VH298-loaded extracellular vesicles launched from gelatin methacryloyl hydrogel facilitate diabetic wound therapeutic by HIF-1α-mediated enhancement of angiogenesis. Acta Biomater. 2022;147:342–55.
Gong M, Wang M, Xu J, Yu B, Wang Y-G, Liu M, et al. Nano-sized extracellular vesicles secreted from GATA-4 modified mesenchymal stem cells promote angiogenesis by delivering Let-7 miRNAs. Cells. 2022;11:1573.
Garofalo M, Villa A, Crescenti D, Marzagalli M, Kuryk L, Limonta P, et al. Heterologous and cross-species tropism of cancer-derived extracellular vesicles. Theranostics. 2019;9:5681–93.
Kojima R, Bojar D, Rizzi G, Hamri GC-E, El-Baba MD, Saxena P, et al. Designer exosomes produced by implanted cells intracerebrally ship therapeutic cargo for Parkinson’s illness therapy. Nat Commun. 2018;9:1305.
Yerneni SS, Lathwal S, Shrestha P, Shirwan H, Matyjaszewski Okay, Weiss L, et al. Fast on-demand extracellular vesicle augmentation with versatile oligonucleotide tethers. ACS Nano. 2019;13:10555–65.
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wooden MJA. Supply of siRNA to the mouse mind by systemic injection of focused exosomes. Nat Biotechnol. 2011;29:341–5.
Liang Y, Xu X, Li X, Xiong J, Li B, Duan L, et al. Chondrocyte-targeted microRNA supply by engineered exosomes towards a cell-free osteoarthritis remedy. ACS Appl Mater Interfaces. 2020;12:36938–47.
Smyth T, Petrova Okay, Payton NM, Persaud I, Redzic JS, Graner MW, et al. Floor functionalization of exosomes utilizing click on chemistry. Bioconjug Chem. 2014;25:1777–84.
Antes TJ, Middleton RC, Luther KM, Ijichi T, Peck KA, Liu WJ, et al. Concentrating on extracellular vesicles to injured tissue utilizing membrane cloaking and floor show. J Nanobiotechnol. 2018;16:61.
Zhuang M, Du D, Pu L, Tune H, Deng M, Lengthy Q, et al. SPION-decorated exosome delivered BAY55-9837 concentrating on the pancreas via magnetism to enhance the blood GLC response. Small. 2019;15: e1903135.
Ma Y, Zhang Y, Han R, Li Y, Zhai Y, Qian Z, et al. A cascade synergetic technique induced by photothermal impact based mostly on platelet exosome nanoparticles for tumor remedy. Biomaterials. 2022;282: 121384.
Pluchino S, Smith JA. Explicating exosomes: reclassifying the rising stars of intercellular communication. Cell. 2019;177:225–7.
Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell. 2019;177:428-45.e18.
Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M, et al. Cell floor tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Can Res. 2010;70:1668–78.
Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins decide organotropic metastasis. Nature. 2015;527:329–35.
Yang L, Han D, Zhan Q, Li X, Shan P, Hu Y, et al. Blood TfR+ exosomes separated by a pH-responsive technique ship chemotherapeutics for tumor remedy. Theranostics. 2019;9:7680–96.
Koning N, Kessen SFM, Van Der Voorn JP, Appelmelk BJ, Jeurink PV, Knippels LMJ, et al. Human milk blocks DC-SIGN-pathogen interplay through MUC1. Entrance Immunol. 2015;6:112.
Sukreet S, Silva BVRE, Adamec J, Cui J, Zempleni J. Galactose and sialo-galactose modifications in glycoproteins on the floor of bovine milk exosome are important for exosome uptake in non-bovine species (OR34-07-19). Curr Develop Nutr. 2019;3:Supplement_1.
Park M, Kang KW. Phosphatidylserine receptor-targeting therapies for the therapy of most cancers. Arch Pharmacal Res. 2019;42:617–28.
Bhatta M, Shenoy GN, Loyall JL, Grey BD, Bapardekar M, Conway A, et al. Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by concentrating on immunosuppressive exosomes in human tumor microenvironments. J Immunother Most cancers. 2021;9:e003148.
Flannagan RS, Canton J, Furuya W, Glogauer M, Grinstein S. The phosphatidylserine receptor TIM4 makes use of integrins as coreceptors to impact phagocytosis. Mol Biol Cell. 2014;25:1511–22.
Matsumoto A, Takahashi Y, Nishikawa M, Sano Okay, Morishita M, Charoenviriyakul C, et al. Position of phosphatidylserine-derived adverse floor costs within the recognition and uptake of intravenously injected B16BL6-derived exosomes by macrophages. J Pharm Sci. 2017;106:168–75.
Berenguer J, Lagerweij T, Zhao XW, Dusoswa S, van der Stoop P, Westerman B, et al. Glycosylated extracellular vesicles launched by glioblastoma cells are adorned by CCL18 permitting for mobile uptake through chemokine receptor CCR8. J Extracell Vesicles. 2018;7:1446660.
Wan Z, Zhao L, Lu F, Gao X, Dong Y, Zhao Y, et al. Mononuclear phagocyte system blockade improves therapeutic exosome supply to the myocardium. Theranostics. 2020;10:218–30.
Koh E, Lee EJ, Nam G-H, Hong Y, Cho E, Yang Y, et al. Exosome-SIRPα, a CD47 blockade will increase most cancers cell phagocytosis. Biomaterials. 2017;121:121–9.
Belhadj Z, He B, Deng H, Tune S, Zhang H, Wang X, et al. A mixed “eat me/don’t eat me” technique based mostly on extracellular vesicles for anticancer nanomedicine. J Extracell Vesicles. 2020;9:1806444.
Ma Q, Liang M, Wu Y, Dou C, Xu J, Dong S, et al. Small extracellular vesicles ship osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic area of interest. J Extracell Vesicles. 2021;10: e12068.
Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si Okay, et al. Engineered exosomes for focused co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon most cancers. J Nanobiotechnol. 2020;18:10.
Wolfram J, Ferrari M. Scientific most cancers nanomedicine. Nano As we speak. 2019;25:85–98.
Shi Y, van der Meel R, Chen X, Lammers T. The EPR impact and past: methods to enhance tumor concentrating on and most cancers nanomedicine therapy efficacy. Theranostics. 2020;10:7921–4.
Tu Y, Dong Y, Wang Okay, Shen S, Yuan Y, Wang J. Intercellular supply of bioorthogonal chemical receptors for enhanced tumor concentrating on and penetration. Biomaterials. 2020;259: 120298.
Walker S, Busatto S, Pham A, Tian M, Suh A, Carson Okay, et al. Extracellular vesicle-based drug supply programs for most cancers therapy. Theranostics. 2019;9:8001–17.
Woo H-Okay, Cho YK, Lee CY, Lee H, Castro CM, Lee H. Characterization and modulation of floor costs to boost extracellular vesicle isolation in plasma. Theranostics. 2022;12:1988–98.
Qiao L, Hu S, Huang Okay, Su T, Li Z, Vandergriff A, et al. Tumor cell-derived exosomes dwelling to their cells of origin and can be utilized as Trojan horses to ship most cancers medicine. Theranostics. 2020;10:3474–87.
Hercher D, Nguyen MQ, Dworak H. Extracellular vesicles and their position in peripheral nerve regeneration. Exp Neurol. 2022;350: 113968.
Zhang L, Wei W, Ai X, Kilic E, Hermann DM, Venkataramani V, et al. Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice through the TGF-β/Smad2/3 pathway. Cell Demise Dis. 2021;12:1068.
Gong C, Zhang X, Shi M, Li F, Wang S, Wang Y, et al. Tumor exosomes reprogrammed by low pH are environment friendly concentrating on autos for good drug supply and customized remedy towards their homologous tumor. Adv Sci. 2021;8:2002787.
Pan S, Zhang Y, Huang M, Deng Z, Zhang A, Pei L, et al. Urinary exosomes-based engineered nanovectors for homologously focused chemo-chemodynamic prostate most cancers remedy through abrogating EGFR/AKT/NF-kB/IkB signaling. Biomaterials. 2021;275: 120946.
Zhu J-Y, Zheng D-W, Zhang M-Okay, Yu W-Y, Qiu W-X, Hu J-J, et al. Preferential most cancers cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic most cancers cell membranes. Nano Lett. 2016;16:5895–901.
Li Y, Gao Y, Gong C, Wang Z, Xia Q, Gu F, et al. A33 antibody-functionalized exosomes for focused supply of doxorubicin towards colorectal most cancers. Nanomed Nanotechnol Biol Med. 2018;14:1973–85.
Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q, et al. Environment friendly induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur J Immunol. 2006;36:1598–607.
Ye Y, Shi Q, Yang T, Xie F, Zhang X, Xu B, et al. Visualized monitoring of tumor-derived extracellular vesicles utilizing CRISPR-Cas9 system. Technol Most cancers Res Deal with. 2022;21:15330338221085370.
Buschow SI, van Balkom BWM, Aalberts M, Heck AJR, Wauben M, Stoorvogel W. MHC class II-associated proteins in B-cell exosomes and potential useful implications for exosome biogenesis. Immunol Cell Biol. 2010;88:851–6.
Montecalvo A, Shufesky WJ, Stolz DB, Sullivan MG, Wang Z, Divito SJ, et al. Exosomes as a short-range mechanism to unfold alloantigen between dendritic cells throughout T cell allorecognition. J Immunol. 2008;180:3081–90.
André F, Chaput N, Schartz NEC, Flament C, Aubert N, Bernard J, et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes switch useful MHC class I/peptide complexes to dendritic cells. J Immunol. 2004;172:2126–36.
Segura E, Nicco C, Lombard B, Véron P, Raposo G, Batteux F, et al. ICAM-1 on exosomes from mature dendritic cells is crucial for environment friendly naive T-cell priming. Blood. 2005;106:216–23.
Cherry LK, Li X, Schwab P, Lim B, Klickstein LB. RhoH is required to keep up the integrin LFA-1 in a nonadhesive state on lymphocytes. Nat Immunol. 2004;5:961–7.
Makgoba MW, Sanders ME, Ginther Luce GE, Dustin ML, Springer TA, Clark EA, et al. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature. 1988;331:86–8.
Yuan D, Zhao Y, Banks WA, Bullock KM, Haney M, Batrakova E, et al. Macrophage exosomes as pure nanocarriers for protein supply to infected mind. Biomaterials. 2017;142:1–12.
Kaur S, Singh SP, Elkahloun AG, Wu W, Abu-Asab MS, Roberts DD. CD47-dependent immunomodulatory and angiogenic actions of extracellular vesicles produced by T cells. Matrix Biol. 2014;37:49–59.
Momen-Heravi F, Bala S, Bukong T, Szabo G. Exosome-mediated supply of functionally energetic miRNA-155 inhibitor to macrophages. Nanomed Nanotechnol Biol Med. 2014;10:1517–27.
Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a serious impediment for intravenous stem cell supply: the pulmonary first-pass impact. Stem Cells Develop. 2009;18:683–92.
Su T, Xiao Y, Xiao Y, Guo Q, Li C, Huang Y, et al. Bone marrow mesenchymal stem cells-derived exosomal MiR-29b-3p regulates aging-associated insulin resistance. ACS Nano. 2019;13:2450–62.
Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M, et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung operate via macrophage immunomodulation. Am J Respir Crit Care Med. 2018;197:104–16.
Riazifar M, Mohammadi MR, Pone EJ, Yeri A, Lässer C, Segaliny AI, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative problems. ACS Nano. 2019;13:6670–88.
Shimoda A, Tahara Y, Sawada S-I, Sasaki Y, Akiyoshi Okay. Glycan profiling evaluation utilizing evanescent-field fluorescence-assisted lectin array: significance of sugar recognition for mobile uptake of exosomes from mesenchymal stem cells. Biochem Biophys Res Commun. 2017;491:701–7.
Wiklander OPB, Nordin JZ, O’Loughlin A, Gustafsson Y, Corso G, Mäger I, et al. Extracellular vesicle in vivo biodistribution is set by cell supply, route of administration and concentrating on. J Extracell Vesicles. 2015;4:26316.
Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, et al. Exosomes mediate the cytoprotective motion of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012;126:2601–11.
Naseri Z, Oskuee RK, Forouzandeh-Moghadam M, Jaafari MR. Supply of LNA-antimiR-142-3p by mesenchymal stem cells-derived exosomes to breast most cancers stem cells reduces tumorigenicity. Stem Cell Rev Rep. 2020;16:541–56.
Lou G, Chen L, Xia C, Wang W, Qi J, Li A, et al. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells enhance hepatocellular carcinoma chemosensitivity via mTOR pathway. J Exp Clin Most cancers Res. 2020;39:4.
Hu Y, Li X, Zhang Q, Gu Z, Luo Y, Guo J, et al. Exosome-guided bone focused supply of antagomir-188 as an anabolic remedy for bone loss. Bioact Mater. 2021;6:2905–13.
Tune H, Li X, Zhao Z, Qian J, Wang Y, Cui J, et al. Reversal of osteoporotic exercise by endothelial cell-secreted bone concentrating on and biocompatible exosomes. Nano Lett. 2019;19:3040–8.
Qu M, Lin Q, Huang L, Fu Y, Wang L, He S, et al. Dopamine-loaded blood exosomes focused to mind for higher therapy of Parkinson’s illness. J Management Launch. 2018;287:156–66.
Zhan Q, Yi Okay, Qi H, Li S, Li X, Wang Q, et al. Engineering blood exosomes for tumor-targeting environment friendly gene/chemo mixture remedy. Theranostics. 2020;10:7889–905.
Zhan Q, Yi Okay, Cui X, Li X, Yang S, Wang Q, et al. Blood exosomes-based focused supply of cPLA2 siRNA and metformin to modulate glioblastoma vitality metabolism for tailoring customized remedy. Neuro Oncol. 2022;noac071.
Melnik BC, John SM, Schmitz G. Milk: an exosomal microRNA transmitter selling thymic regulatory T cell maturation stopping the event of atopy? J Transl Med. 2014;12:43.
Chen W, Wang R, Li D, Zuo C, Wen P, Liu H, et al. Complete evaluation of the glycome and glycoproteome of bovine milk-derived exosomes. J Agric Meals Chem. 2020;68:12692–701.
Agrawal AK, Aqil F, Jeyabalan J, Spencer WA, Beck J, Gachuki BW, et al. Milk-derived exosomes for oral supply of paclitaxel. Nanomed Nanotechnol Biol Med. 2017;13:1627–36.
Brossa A, Fonsato V, Grange C, Tritta S, Tapparo M, Calvetti R, et al. Extracellular vesicles from human liver stem cells inhibit renal most cancers stem cell-derived tumor progress in vitro and in vivo. Int J Most cancers. 2020;147:1694–706.
Németh Okay, Varga Z, Lenzinger D, Visnovitz T, Koncz A, Hegedűs N, et al. Extracellular vesicle launch and uptake by the liver beneath normo- and hyperlipidemia. Cell Mol Life Sci. 2021;78:7589–604.
Wei Z, Chen Z, Zhao Y, Fan F, Xiong W, Tune S, et al. Mononuclear phagocyte system blockade utilizing extracellular vesicles modified with CD47 on membrane floor for myocardial infarction reperfusion damage therapy. Biomaterials. 2021;275: 121000.
Zhang Okay, Chen S, Solar H, Wang L, Li H, Zhao J, et al. two-photon microscopy reveals the contribution of Sox9 cell to kidney regeneration in a mouse mannequin with extracellular vesicle therapy. J Biol Chem. 2020;295:12203–13.
Hong CM, Gangadaran P, Oh JM, Rajendran RL, Gopal A, Zhu L, et al. Radioiodine labeling and in vivo trafficking of extracellular vesicles. Sci Rep. 2021;11:5041.
Heidari N, Abbasi-Kenarsari H, Namaki S, Baghaei Okay, Zali MR, Ghaffari Khaligh S, et al. Adipose-derived mesenchymal stem cell-secreted exosome alleviates dextran sulfate sodium-induced acute colitis by Treg cell induction and inflammatory cytokine discount. J Cell Physiol. 2021;236:5906–20.
Nojehdehi S, Soudi S, Hesampour A, Rasouli S, Soleimani M, Hashemi SM. Immunomodulatory results of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes. J Cell Biochem. 2018;119:9433–43.
Zhou X, Li Z, Solar W, Yang G, Xing C, Yuan L. Supply efficacy variations of intravenous and intraperitoneal injection of exosomes: views from monitoring dye labeled and MiRNA encapsulated exosomes. Curr Drug Deliv. 2020;17:186–94.
Arntz OJ, Pieters BCH, Oliveira MC, Broeren MGA, Bennink MB, de Vries M, et al. Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse fashions. Mol Nutr Meals Res. 2015;59:1701–12.
Nazimek Okay, Bryniarski Okay, Ptak W, Groot Kormelink T, Askenase PW. Orally administered exosomes suppress mouse delayed-type hypersensitivity by delivering miRNA-150 to antigen-primed macrophage APC focused by exosome-surface anti-peptide antibody mild chains. Int J Mol Sci. 2020;21:5540.
Umezu T, Takanashi M, Murakami Y, Ohno S-I, Kanekura Okay, Sudo Okay, et al. Acerola exosome-like nanovesicles to systemically ship nucleic acid drugs through oral administration. Mol Ther Strategies Clin Dev. 2021;21:199–208.
Rivoltini L, Chiodoni C, Squarcina P, Tortoreto M, Villa A, Vergani B, et al. TNF-related apoptosis-inducing ligand (TRAIL)-armed exosomes ship proapoptotic indicators to tumor website. Clin Most cancers Res. 2016;22:3499–512.
Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and supply effectivity of unmodified tumor-derived exosomes. J Management Launch. 2015;199:145–55.
Wang D, Wan Z, Yang Q, Chen J, Liu Y, Lu F, et al. Sonodynamical reversion of immunosuppressive microenvironment in prostate most cancers through engineered exosomes. Drug Supply. 2022;29:702–13.
Wilke S, Krausze J, Büssow Okay. Crystal construction of the conserved area of the DC lysosomal related membrane protein: implications for the lysosomal glycocalyx. BMC Biol. 2012;10:62.
Hung ME, Leonard JN. Stabilization of exosome-targeting peptides through engineered glycosylation. J Biol Chem. 2015;290:8166–72.
Li Z, Zhou X, Wei M, Gao X, Zhao L, Shi R, et al. In vitro and in vivo RNA inhibition by CD9-HuR functionalized exosomes encapsulated with miRNA or CRISPR/dCas9. Nano Lett. 2019;19:19–28.
Ohno S-I, Takanashi M, Sudo Okay, Ueda S, Ishikawa A, Matsuyama N, et al. Systemically injected exosomes focused to EGFR ship antitumor microRNA to breast most cancers cells. Mol Ther. 2013;21:185–91.
Rountree RB, Mandl SJ, Nachtwey JM, Dalpozzo Okay, Do L, Lombardo JR, et al. Exosome concentrating on of tumor antigens expressed by most cancers vaccines can enhance antigen immunogenicity and therapeutic efficacy. Can Res. 2011;71:5235–44.
Tian T, Cao L, He C, Ye Q, Liang R, You W, et al. Focused supply of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics. 2021;11:6507–21.
Wang J, Li W, Lu Z, Zhang L, Hu Y, Li Q, et al. The usage of RGD-engineered exosomes for enhanced concentrating on skill and synergistic remedy towards angiogenesis. Nanoscale. 2017;9:15598–605.
Wang X, Chen Y, Zhao Z, Meng Q, Yu Y, Solar J, et al. Engineered exosomes with ischemic myocardium-targeting peptide for focused remedy in myocardial infarction. J Am Coronary heart Assoc. 2018;7: e008737.
Mentkowski KI, Lang JK. Exosomes engineered to specific a cardiomyocyte binding peptide show improved cardiac retention in vivo. Sci Rep. 2019;9:10041.
Jia G, Han Y, An Y, Ding Y, He C, Wang X, et al. NRP-1 focused and cargo-loaded exosomes facilitate simultaneous imaging and remedy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–16.
Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M. Systemic supply of microRNA-21 antisense oligonucleotides to the mind utilizing T7-peptide adorned exosomes. J Management Launch. 2020;317:273–81.
Bai J, Duan J, Liu R, Du Y, Luo Q, Cui Y, et al. Engineered concentrating on tLyp-1 exosomes as gene remedy vectors for environment friendly supply of siRNA into lung most cancers cells. Asian J Pharm Sci. 2020;15:461–71.
Xu X, Liang Y, Li X, Ouyang Okay, Wang M, Cao T, et al. Exosome-mediated supply of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2021;269: 120539.
Bellavia D, Raimondo S, Calabrese G, Forte S, Cristaldi M, Patinella A, et al. Interleukin 3- receptor focused exosomes inhibit and persistent myelogenous leukemia cell progress. Theranostics. 2017;7:1333–45.
Ran N, Gao X, Dong X, Li J, Lin C, Geng M, et al. Results of exosome-mediated supply of myostatin propeptide on useful restoration of mdx mice. Biomaterials. 2020;236: 119826.
Kanuma T, Yamamoto T, Kobiyama Okay, Moriishi E, Masuta Y, Kusakabe T, et al. CD63-mediated antigen supply into extracellular vesicles through DNA vaccination leads to strong CD8 T cell responses. J Immunol. 2017;198:4707–15.
Xu L, Faruqu FN, Liam-Or R, Abu Abed O, Li D, Venner Okay, et al. Design of experiment (DoE)-driven and uptake research of exosomes for pancreatic most cancers supply enabled by copper-free click on chemistry-based labelling. J Extracell Vesicles. 2020;9:1779458.
Tran PHL, Xiang D, Tran TTD, Yin W, Zhang Y, Kong L, et al. Exosomes and nanoengineering: a match made for precision therapeutics. Adv Mater. 2020;32: e1904040.
Han Q, Xie QR, Li F, Cheng Y, Wu T, Zhang Y, et al. Focused inhibition of SIRT6 through engineered exosomes impairs tumorigenesis and metastasis in prostate most cancers. Theranostics. 2021;11:6526–41.
Zou J, Shi M, Liu X, Jin C, Xing X, Qiu L, et al. Aptamer-functionalized exosomes: elucidating the mobile uptake mechanism and the potential for cancer-targeted chemotherapy. Anal Chem. 2019;91:2425–30.
Xiang D, Zheng C, Zhou S-F, Qiao S, Tran PH-L, Pu C, et al. Superior efficiency of aptamer in tumor penetration over antibody implication of aptamer-based theranostics in strong tumors. Theranostics. 2015;5:1083–97.
Macdonald J, Henri J, Goodman L, Xiang D, Duan W, Shigdar S. Growth of a bifunctional aptamer concentrating on the transferrin receptor and epithelial cell adhesion molecule (EpCAM) for the therapy of mind most cancers metastases. ACS Chem Neurosci. 2017;8:777–84.
Yao X, Lyu P, Yoo Okay, Yadav MK, Singh R, Atala A, et al. Engineered extracellular vesicles as versatile ribonucleoprotein supply autos for environment friendly and secure CRISPR genome modifying. J Extracell Vesicles. 2021;10: e12076.
Tran PHL, Xiang D, Nguyen TNG, Tran TTD, Chen Q, Yin W, et al. Aptamer-guided extracellular vesicle theranostics in oncology. Theranostics. 2020;10:3849–66.
Luo Z-W, Li F-X-Z, Liu Y-W, Rao S-S, Yin H, Huang J, et al. Aptamer-functionalized exosomes from bone marrow stromal cells goal bone to advertise bone regeneration. Nanoscale. 2019;11:20884–92.
Ren X, Zhao Y, Xue F, Zheng Y, Huang H, Wang W, et al. Exosomal DNA aptamer concentrating on α-synuclein aggregates decreased neuropathological deficits in a mouse Parkinson’s illness mannequin. Mol Ther Nucleic Acids. 2019;17:726–40.
Gao X, Ran N, Dong X, Zuo B, Yang R, Zhou Q, et al. Anchor peptide captures, targets, and masses exosomes of various origins for diagnostics and remedy. Sci Transl Med. 2018;10:aat0195.
Dong X, Lei Y, Yu Z, Wang T, Liu Y, Han G, et al. Exosome-mediated supply of an anti-angiogenic peptide inhibits pathological retinal angiogenesis. Theranostics. 2021;11:5107–26.
Tamura R, Uemoto S, Tabata Y. Augmented liver concentrating on of exosomes by floor modification with cationized pullulan. Acta Biomater. 2017;57:274–84.
Zhu S, Huang H, Liu D, Wen S, Shen L, Lin Q. Augmented mobile uptake and homologous concentrating on of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety enchancment. Bioact Mater. 2022;15:469–81.
Nakase I, Futaki S. Mixed therapy with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic supply of exosomes. Sci Rep. 2015;5:10112.
Zheng Z, Li Z, Xu C, Guo B, Guo P. Folate-displaying exosome mediated cytosolic supply of siRNA avoiding endosome trapping. J Management Launch. 2019;311–312:43–9.
Armstrong JPK, Holme MN, Stevens MM. Re-engineering extracellular vesicles as good nanoscale therapeutics. ACS Nano. 2017;11:69–83.
Youn S-W, Li Y, Kim Y-M, Sudhahar V, Abdelsaid Okay, Kim HW, et al. Modification of cardiac progenitor cell-derived exosomes by miR-322 offers safety towards myocardial infarction via Nox2-dependent angiogenesis. Antioxidants. 2019;8:18.
Zhu L-P, Tian T, Wang J-Y, He J-N, Chen T, Pan M, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac restore via miR-125b-mediated prevention of cell demise in myocardial infarction. Theranostics. 2018;8:6163–77.
Hu S, Wang X, Li Z, Zhu D, Cores J, Wang Z, et al. Platelet membrane and stem cell exosome hybrid enhances mobile uptake and concentrating on to coronary heart damage. Nano As we speak. 2021;39:101210.
Tian T, Zhang H-X, He C-P, Fan S, Zhu Y-L, Qi C, et al. Floor functionalized exosomes as focused drug supply autos for cerebral ischemia remedy. Biomaterials. 2018;150:137–49.
Liu Y, Li D, Liu Z, Zhou Y, Chu D, Li X, et al. Focused exosome-mediated supply of opioid receptor Mu siRNA for the therapy of morphine relapse. Sci Rep. 2015;5:17543.
Guo L, Huang Z, Huang L, Liang J, Wang P, Zhao L, et al. Floor-modified engineered exosomes attenuated cerebral ischemia/reperfusion damage by concentrating on the supply of quercetin in direction of impaired neurons. J Nanobiotechnol. 2021;19:141.
Wang J, Tang W, Yang M, Yin Y, Li H, Hu F, et al. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug supply system for focused glioma remedy. Biomaterials. 2021;273: 120784.
Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, et al. Engineering macrophage-derived exosomes for focused paclitaxel supply to pulmonary metastases: in vitro and in vivo evaluations. Nanomed Nanotechnol Biol Med. 2018;14:195–204.
Cho BS, Kim JO, Ha DH, Yi YW. Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis. Stem Cell Res Ther. 2018;9:187. https://doi.org/10.1186/s13287-018-0939-5.
Tian Y, Li S, Tune J, Ji T, Zhu M, Anderson GJ, et al. A doxorubicin supply platform utilizing engineered pure membrane vesicle exosomes for focused tumor remedy. Biomaterials. 2014;35:2383–90.
Lee H, Park H, Noh GJ, Lee ES. pH-responsive hyaluronate-anchored extracellular vesicles to advertise tumor-targeted drug supply. Carbohydrate Polym. 2018;202:323–33. https://doi.org/10.1016/j.carbpol.2018.08.141.
de Abreu RC, Fernandes H, da Costa Martins PA, Sahoo S, Emanueli C, Ferreira L. Native and bioengineered extracellular vesicles for cardiovascular therapeutics. Nat Rev Cardiol. 2020;17:685–97.
Zhang E, Liu Y, Han C, Fan C, Wang L, Chen W, et al. Visualization and Identification of bioorthogonally labeled exosome proteins following systemic administration in mice. Entrance Cell Dev Biol. 2021;9: 657456.
Xia T, Kovochich M, Liong M, Zink JI, Nel AE. Cationic polystyrene nanosphere toxicity relies on cell-specific endocytic and mitochondrial damage pathways. ACS Nano. 2008;2:85–96.
Qi H, Liu C, Lengthy L, Ren Y, Zhang S, Chang X, et al. Blood exosomes endowed with magnetic and concentrating on properties for most cancers remedy. ACS Nano. 2016;10:3323–33.
Kim HY, Kim TJ, Kang L, Kim Y-J, Kang MK, Kim J, et al. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for concentrating on and therapy of ischemic stroke. Biomaterials. 2020;243: 119942.
Kutchy NA, Ma R, Liu Y, Buch S, Hu G. Extracellular vesicle-mediated supply of ultrasmall superparamagnetic iron oxide nanoparticles to mice mind. Entrance Pharmacol. 2022;13: 819516.
Wang J, Wang H, Yan L, Hu Z, Wu X, Li F. Twin focused and pH-responsive gold nanorods with improved chemotherapy and photothermal ablation for synergistic most cancers therapy. RSC Adv. 2019;9:5270–81.
Yim N, Ryu S-W, Choi Okay, Lee KR, Lee S, Choi H, et al. Exosome engineering for environment friendly intracellular supply of soluble proteins utilizing optically reversible protein-protein interplay module. Nat Commun. 2016;7:12277.
Foglietta F, Canaparo R, Cossari S, Panzanelli P, Dosio F, Serpe L. Ultrasound triggers hypericin activation resulting in multifaceted anticancer exercise. Pharmaceutics. 2022;14:1102.
Liu Y, Bai L, Guo Okay, Jia Y, Zhang Okay, Liu Q, et al. Centered ultrasound-augmented concentrating on supply of nanosonosensitizers from homogenous exosomes for enhanced sonodynamic most cancers remedy. Theranostics. 2019;9:5261–81.
Ma N, Wu C, Meng Z. In vivo imaging and monitoring of exosomes for theranostics. J Innov Decide Well being Sci. 2021;14:2130005.
Verweij FJ, Balaj L, Boulanger CM, Carter DRF, Compeer EB, D’Angelo G, et al. The ability of imaging to grasp extracellular vesicle biology in vivo. Nat Strategies. 2021;18:1013–26.
Lai J, Huang C, Guo Y, Rao L. Engineered extracellular vesicles and their mimics in cardiovascular illnesses. J Management Launch. 2022;347:27–43.
Rayamajhi S, Nguyen TDT, Marasini R, Aryal S. Macrophage-derived exosome-mimetic hybrid vesicles for tumor focused drug supply. Acta Biomater. 2019;94:482–94.
Li Y-J, Wu J-Y, Liu J, Xu W, Qiu X, Huang S, et al. Synthetic exosomes for translational nanomedicine. J Nanobiotechnol. 2021;19:242.
Cheng Y, Zeng Q, Han Q, Xia W. Impact of pH, temperature and freezing-thawing on amount adjustments and mobile uptake of exosomes. Protein Cell. 2019;10:295–9.
Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, et al. Microenvironmental pH is a key issue for exosome site visitors in tumor cells. J Biol Chem. 2009;284:34211–22.
Maroto R, Zhao Y, Jamaluddin M, Popov VL, Wang H, Kalubowilage M, et al. Results of storage temperature on airway exosome integrity for diagnostic and useful analyses. J Extracell Vesicles. 2017;6:1359478.
Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z. miRNA in plasma exosome is secure beneath totally different storage situations. Molecules. 2014;19:1568–75.
Noren Hooten N, Yáñez-Mó M, DeRita R, Russell A, Quesenberry P, Ramratnam B, et al. Hitting the bullseye: are extracellular vesicles on course? J Extracell Vesicles. 2020;10: e12032.
Nordin JZ, Lee Y, Vader P, Mäger I, Johansson HJ, Heusermann W, et al. Ultrafiltration with size-exclusion liquid chromatography for prime yield isolation of extracellular vesicles preserving intact biophysical and useful properties. Nanomed Nanotechnol Biol Med. 2015;11:879–83.
Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New applied sciences for evaluation of extracellular vesicles. Chem Rev. 2018;118:1917–50.
Ban J-J, Lee M, Im W, Kim M. Low pH will increase the yield of exosome isolation. Biochem Biophys Res Commun. 2015;461:76–9.
Taraboletti G, D’Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D, et al. Bioavailability of VEGF in tumor-shed vesicles relies on vesicle burst induced by acidic pH. Neoplasia. 2006;8:96–103.
Zhuang M, Chen X, Du D, Shi J, Deng M, Lengthy Q, et al. SPION adorned exosome supply of TNF-α to most cancers cell membranes via magnetism. Nanoscale. 2020;12:173–88.
Shi X, Cheng Q, Hou T, Han M, Smbatyan G, Lang JE, et al. Genetically engineered cell-derived nanoparticles for focused breast most cancers immunotherapy. Mol Ther. 2020;28:536–47.
